Avid Bioservices, Inc.

Avid Bioservices, Inc.

$12.39
-0.03 (-0.24%)
NASDAQ Capital Market
USD, US
Biotechnology

CDMO Price Chart

Basic
Market Cap$785.47M
Price$12.39
52 Week Range5.65-12.48
Beta1.41
Margins
Gross Profit Margin7.68%
Operating Profit Margin-13.55%
Net Profit Margin-101.07%
Valuation (TTM)
P/E Ratio-5.20
Price to Sales Ratio5.27
Price to Book Ratio17.65
PEG Ratio0.98

Industry

Biotechnology

Sector

Healthcare

Full-Time Employees

371

IPO Date

1994-04-04T00:00:00.000Z

Description

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Phone

714 508 6100

Address

2642 Michelle Drive, Tustin, CA, 92780, US

CIK

0000704562